Health and Wellness

The funds will be used to increase product offerings, expand the commercial team and move into the substance use disorder space.  

Neurotechnology company, Grey Matter Neurosciences, announced it secured $14 million in seed financing, which will be used to develop an ultrasound headset for individuals with Alzheimer's disease and test that device in clinical trials.

PanopticAI also claims to be the first in the city to obtain US FDA clearance for software as a medical device.

The company will use the funds to expand access to its hormonal healthcare platform across the U.S.

DeepScribe will be the first ambient AI partner for Flatiron Health, and will integrate with Flatiron's OncoEMR.   

The partnership gives Lantern clients entry into customized substance use disorder treatment and telemedicine services.  

The olivia app will allow patients to aggregate their health data in a central location.

The aim of the partnership is to allow healthcare providers to offer precision medicine support tools.   

SpaceX's Dragon spacecraft, which recently returned from the ISS, included 50 biotechnology, physical science and student research payloads.

Bernke Papenburg, program manager of Robotics at Rijnstate Hospital in the Netherlands, previews her HIMSS25 talk, where she will discuss the challenges associated with deploying digital technology in a hospital setting.